Skip to main content
See every side of every news story
Published • loading... • Updated

Research Analysts Issue Forecasts for Genmab A/S Q2 Earnings

Summary by MarketBeat
Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) - Investment analysts at HC Wainwright decreased their Q2 2027 earnings per share (EPS) estimates for Genmab A/S in a research note issued to investors on Friday, November 6th. HC Wainwright analyst R. Selvaraju now forecasts that the company will

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Monday, November 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal